ATF3, a stress inducible, pro-apoptotic gone in β cell destruction and the development of type I and type II diabetes

被引：0
|
作者：
Hartman, MG
Kim, ML
Lu, D
Wolfgang, CD
Guttridge, D
Frankel, W
Kociba, GJ
Hai, T
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1883
引用
收藏
页码：A458 / A458
页数：1
相关论文
共 50 条
  • [41] Development of Smad3 (-/-) alveolar type II cell lines
    Ramos, C. G.
    Tiozzo, C.
    Minoo, P.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 200 - 200
  • [42] DISCORDANT EXPRESSION OF TYPE-II AND TYPE-I CELL MARKERS DURING FETAL LUNG DEVELOPMENT
    DANTO, SI
    ZABSKI, SM
    CRANDALL, ED
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A939 - A939
  • [43] Decreased Adiponectin Levels in Obese Mice with Polygenetic Susceptibility to Type 2 Diabetes Is Linked to Altered miRNA Levels of the ATF3 Gene In Visceral Adipose Tissue
    Adi, Nikhil
    Adi, Jennipher
    Cesar, Liliana
    Hollar, Danielle
    Kurlansky, Paul
    Agatston, Arthur
    Webster, Keith A.
    CIRCULATION, 2008, 118 (18) : S278 - S278
  • [44] CYP3A IS EXPRESSED IN MOUSE HEART VENTRICLES AND IS DOWN REGULATED IN TYPE I AND TYPE II DIABETES.
    Patoine, D.
    Mercier, P.
    Pilote, S.
    Petit, M.
    Drolet, B.
    Simard, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S77 - S78
  • [45] TYPE I AND TYPE II DIABETES: TWO DIFFERENT DISEASES, TWO DIFFERENT MODULATING EFFECTS ON CYP3A
    Petit, M.
    Pilote, S.
    Patoine, D.
    Drolet, B.
    Simard, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S24 - S25
  • [46] Development of a cell based macro-encapsulation approach for the treatment of type I diabetes
    Baetge, E
    EUROPEAN CYTOKINE NETWORK, 2000, 11 (02) : 336 - 336
  • [47] Cell-type-specific expression of murine multifunctional galectin-3 and its association with follicular atresia/luteolysis in contrast to pro-apoptotic galectins-1 and-7
    Lohr, Michaela
    Kaltner, Herbert
    Lensch, Martin
    Andre, Sabine
    Sinowatz, Fred
    Gabius, Hans-Joachim
    HISTOCHEMISTRY AND CELL BIOLOGY, 2008, 130 (03) : 567 - 581
  • [48] Inhibition of histone deacetylase attenuates development of type I diabetes through reduction of oxidant stress
    Lee, H.
    Kim, I.
    FEBS OPEN BIO, 2018, 8 : 228 - 229
  • [49] DEVELOPMENT OF GUINEA PIG MODELS OF TYPE I AND TYPE II DIABETES FOR STUDYING QT-PROLONGING DRUGS IN VIVO.
    Caillier, B.
    Levac, X.
    Pilote, S.
    Patoine, D.
    Daleau, P.
    Simard, C.
    Drolet, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S14 - S14
  • [50] Hyperglycemia Induced Osmotic Disequilibrium, Oxidative Stress and Cell Death in Type II Diabetes Patients
    Das, Madhumita
    Bhattacharya, Rinki
    Biswas, Rashmi
    Chakraborty, Indrani
    Chanda, Sarmishtha
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2015, 6 (03): : 189 - 200
12345